Research status of common recurrence risk prediction tools for hormone receptor-positive breast cancer
10.12025/j.issn.1008-6358.2024.20231824
- VernacularTitle:激素受体阳性乳腺癌常用复发风险预测工具研究现状
- Author:
Lihua ZHANG
1
;
Meihong SHENG
Author Information
1. 南通市第一人民医院影像科,南通 226001
- Keywords:
breast cancer;
hormone receptor;
recurrence risk;
prognosis;
prediction model
- From:
Chinese Journal of Clinical Medicine
2024;31(3):499-507
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer is one of the malignant tumors that seriously threaten the health of women worldwide,with hormone receptor(HR)positivity being its most common molecular subtype.The heterogeneity of breast cancer leads to varying risks of recurrence after surgery for patients,thus requiring highly sensitive recurrence risk prediction tools to help clinical doctors assess patients'prognoses and to develop personalized treatment plans.Currently,widely used recurrence risk prediction tools developed based on multi-gene testing or clinical pathological factors for HR-positive breast cancer patients after surgery,such as Oncotype DX,IHC 4 scores.In addition,prognostic models based on imaging features are also gradually being applied in clinical practice.The recurrence risk prediction tools can more accurately assess the risk of recurrence and prognosis of breast cancer patients after surgery,guide individualized clinical diagnosis and treatment plans for patients,improve the quality of life of patients,and prolong overall survival.
